Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Howe Jill Ann
Chief Financial Officer at Lineage Cell Therapeutics. Filing since 16 Aug 2024.
CIK 0001892397
Company
Date
Role
Action
Shares
Amount
Of holding
LCTX
Lineage Cell Therapeutics, Inc.
26 Nov 2024
Chief Financial Officer
Bought
15,000
$8.85K
143%
LCTX
Lineage Cell Therapeutics, Inc.
16 Aug 2024
Chief Financial Officer
Bought
10,500
$9.35K
opened
2 decisions on file.
